Overview

A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule

Status:
Completed

Trial end date:
2010-01-20

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether albaconazole tablets and albaconazole capsules (single 400mg dose) act in the body in the same way over a period of time.

Phase:

Phase 1

Details

Lead Sponsor:

Stiefel, a GSK Company

Collaborator:

GlaxoSmithKline

Treatments:

Albaconazole